Compare Docusign Inc (DOCU) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Docusign Inc vs UnitedHealth Group Inc — how do they compare? Docusign Inc trades at $71.08 (market cap $13.35B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 24.9× Docusign Inc's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while Docusign Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Docusign Inc for 71 Days and UnitedHealth Group Inc for 97 Days on average.
| DOCU | UNH | |
|---|---|---|
Market Cap | $13.35B | $332.96B |
Volume | 3,158,858 | 7,273,749 |
Sector | Technology | Health |
52-Week High | $73.14 | $436.35 |
52-Week Low | $41.75 | $259.02 |
Typical Hold Time | 71 Days | 97 Days |
Enterprise Value | $12.76B | $374.82B |
Dividend Yield | — | 2.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DOCU trades at $71.43, up 3.67% with strong technical momentum and bullish moving averages. The company demonstrates robust revenue growth, improving from $2.1B in 2022 to $3.0B in 2025, with net income turning positive at $1.07B. Recent earnings beats and AI-driven contract processing capabilities support the bullish case, though valuation multiples remain elevated with a P/E of 43.55.
Outlook remains positive with continued earnings momentum and AI integration driving efficiency, but risks include insider selling activity and competitive pressures in the e-signature market. Analyst consensus is cautious with 64% hold ratings, though technical indicators suggest near-term strength with support at $70 and resistance at $72.
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Docusign Inc
DocuSign offers the Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its IPO in May 2018.
Read more on DOCU →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
